Gripas klinikiniai tyrimai Ilinoisas
7 tyrimai dėl Gripas ieško dalyvių vietose Ilinoisas.
Miestai Ilinoisas
Oficialus tyrimo tekstas (anglų kalba)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Evanston
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT05624450High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
- Ann Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviai2 fazė
Amžius nuo 3 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT05947071A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
- GSK Investigational Site, Chicago
- GSK Investigational Site, Morton
- GSK Investigational Site, Peoria
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
Amžius 65 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT07805707Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
- AMR Chicago- Site Number : 8400005, Oak Brook
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT07779408Dime La VerDAD: Verify, Debunk, and Disseminate
- University of Chicago, Chicago
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-08-26 · NCT06417762The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
- Ann and Robert Lurie's Children Hospital of Chicago, Chicago
Renkami dalyviaiLaukiami sveiki savanoriai
6 Months – 99 Years · Visoms lytims · Atnaujinta 2026-04-08 · NCT05832307Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- University of Illinois Health, Chicago
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2024-07-12 · NCT02735707Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.